| Typicality: | 0.346 |
| Saliency: | 0.225 |
| for rheumatoid arthritis | 3 | purpose |
| by the european medicines agency | 2 | other |
| medicine → be approved in → the eu | 6 |
| medicine → be approved in → europe | 5 |
| negative | neutral | positive |
| 0.257 | 0.446 | 0.297 |
| Raw frequency | 11 |
| Normalized frequency | 0.225 |
| Modifier score | 0.500 |
| Perplexity | 141.200 |